Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

660
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
660
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

5.2K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diagnostic Challenge of Recurrent Dermatofibrosarcoma Protuberans Mimicking Other Spindle Cell Lesions: Importance of Immunohistochemistry in Diagnosis.

Cureusยท2026
Same author

CT in adult patients with Polytrauma: current practices, protocol optimization, structured reporting and future directions.

Emergency radiologyยท2026
Same author

Primary Platinum-Resistant Ovarian Cancer: Clinicopathologic Correlates and Outcomes From a Multicenter Prospective Indian Registry.

JCO global oncologyยท2026
Same author

Prevalence of Cervical Lymphadenopathy in Acute CNS Infections - Testing Glymphatics in Humans.

Neurology Indiaยท2026
Same author

"Treatment Patterns and Survival Outcomes in Periampullary Carcinoma: A Multicentric Retrospective Study from the Indian Subcontinent".

Indian journal of surgical oncologyยท2026
Same author

Assessing physical activity barriers and facilitators among Latinos/as: Qualitative findings from a citizen science pilot study in a Los Angeles park.

Health & placeยท2026

Related Experiment Video

Updated: Apr 21, 2026

Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats
08:55

Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats

Published on: April 15, 2016

8.9K

Low-dose rasburicase in hematologic malignancies.

Somasundaram Jayabose1, Vignesh Kumar, Rajeswari Dhanabalan

  • 1Division of Pediatric Hematology-Oncology, Meenakshi Mission Hospital & Research Centre, Lake Area, Melur Road, Madurai, Tamil Nadu, India, sjayabose@gmail.com.

Indian Journal of Pediatrics
|October 24, 2014
PubMed
Summary

Low-dose rasburicase effectively reduced plasma uric acid in South Indian children with hematologic malignancies and tumor lysis syndrome (TLS). This treatment demonstrated safety, potentially lowering the risk of renal failure in this pediatric population.

More Related Videos

Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver
09:02

Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver

Published on: July 31, 2016

11.4K

Related Experiment Videos

Last Updated: Apr 21, 2026

Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats
08:55

Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats

Published on: April 15, 2016

8.9K
Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver
09:02

Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver

Published on: July 31, 2016

11.4K

Area of Science:

  • Pediatric Oncology
  • Nephrology
  • Pharmacology

Background:

  • Hematologic malignancies are common in children.
  • Tumor lysis syndrome (TLS) is a serious complication of chemotherapy.
  • Effective management of TLS is crucial to prevent renal failure.

Purpose of the Study:

  • To evaluate the efficacy and safety of low-dose rasburicase in Indian children with hematologic malignancies.
  • To assess the impact of rasburicase on plasma uric acid levels and renal function.
  • To determine the optimal dosing regimen for rasburicase in this population.

Main Methods:

  • Retrospective analysis of 41 children with hematologic malignancies and TLS.
  • Treatment with rasburicase at doses of 0.1-0.15 mg/kg, repeated as needed.
  • Monitoring of plasma uric acid, creatinine, and phosphate levels.

Main Results:

  • Rasburicase significantly reduced plasma uric acid by a median of 80% within 6 hours.
  • Most children required only one dose; 12 needed 2-3 doses.
  • No anaphylaxis, hemolysis, or deaths related to TLS were observed; one child required dialysis.

Conclusions:

  • Low-dose rasburicase (0.1-0.15 mg/kg) is safe and effective in reducing plasma uric acid in Indian children with lymphoid malignancies.
  • This regimen may significantly decrease the risk of renal failure associated with TLS.
  • Rasburicase offers a valuable therapeutic option for managing TLS in pediatric hematologic malignancies.